Trulieve is a vertically integrated “seed to sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery.

Average volume for TRUL is 778 shares per day. Today’s news caused the volume to spike to 118 thousand shares to a new 52 week high of $0.25.

Trulieve Cannabis Corp. Press Release:

QUINCY, FL , Sept. 24, 2018 /CNW/ – Trulieve Cannabis Corp. (CSE: TRUL) (“Trulieve” or the “Company”) today announces its financial results for the three and six-month periods ended June 30, 2018 . The Company’s second quarter 2018 financial statements have been filed as part of its listing statement with the Canadian Securities Exchange (“CSE”). This news release is not in any way a substitute for reading those financial statements, including the notes to the financial statements.

Unless otherwise stated, all currency is expressed in U.S. dollars.

Q2 2018 Highlights

  • 16 dispensaries in operation
  • 83,000 active unique patients
  • Revenue grew from $15.2 million in Q1 2018 to $23.3 million in Q2 2018.
  • EBITDA1increased from $11.2 million in Q1 2018 to $14.3 million in Q2 2018

“The second quarter of 2018 demonstrated our ability to scale our business profitably with growth in dispensaries and patients served driving growth in revenue and EBITDA1,” said Kim Rivers , CEO of Trulieve. “This momentum is continuing in the current quarter and we expect strong results throughout 2018.”

Results of Operations

(millions of U.S. dollars) 2017 2018 Q1 % change 2018 Q2
Total Revenue 19.8 15.2 53.3 23.3
Gross Margin2 8.7 10.7 61.7 17.3
Gross Margin % 43.9 69.3 6.9 74.1
Operating Expenses 8.3 4.6 30.4 6.0
Operating Expenses % 42.0 30.1 (14.3) 25.8
EBITDA1 10.1 11.2 27.7 14.3

1. EBITDA is a non-IFRS financial measure. While Trulieve believes that this measure is useful for the evaluation and assessment of its performance, it does not have any standard meaning prescribed by IFRS, is unlikely to be comparable to similar measures presented by other issuers, and should not be considered as an alternative to comparable measures determined in accordance with IFRS.
2. Gross Margin does not include net-effect of change in fair value of biological assets i.e. gain on biological assets.

About Trulieve
Trulieve is a vertically integrated “seed to sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

SOURCE Trulieve Cannabis Corp.

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  EmergingGrowth.com, or its associates may have a position either long or short in any company mentioned herein. Please read our full disclosure, which can be found here, https://emerginggrowth.com/disclosure/. Please consult an investment professional before investing in anything viewed within this article or any other portion of EmergingGrowth.com. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

LEAVE A REPLY

Please enter your comment!
Please enter your name here